YY1 could also promote the survival of tumor cells in the presence of chemotherapy drugs by repressing anti-apoptotic genes such as Bcl2-interacting mediator of cell death (Bim) and increasing protein B-cell lymphoma-extra-large (BCL-xL) [57,96,104]. Here, BCL2L1 is linked to neoplasm.